Bioactive lipids accumulate in stored red blood cells despite leukoreduction: a targeted metabolomics study

Transfusion

Volumn 56, Issue 10, 2016, Pages 2560-2570

  Fu, Xiaoyun ^a,b   Felcyn, Jacob R ^a   Odem Davis, Katherine ^a   Zimring, James C ^a,b,c  

^a Bloodworks Northwest Research Institute   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

12 HYDROXYICOSATETRAENOIC ACID; ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; LINOLEIC ACID; OXYLIPIN; POLYUNSATURATED FATTY ACID; UNSATURATED FATTY ACID;

ARTICLE; BLOOD DONOR; CENTRIFUGATION; HEMATOCRIT; HUMAN; LIPID DEGRADATION; LIPID STORAGE; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLOMICS; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; ADVERSE EFFECTS; BLOOD STORAGE; ERYTHROCYTE; ERYTHROCYTE TRANSFUSION; LEUKAPHERESIS; LEUKOCYTE COUNT; LIPID METABOLISM; METABOLISM; PROCEDURES; TIME FACTOR;

BLOOD PRESERVATION; ERYTHROCYTE TRANSFUSION; ERYTHROCYTES; FATTY ACIDS, UNSATURATED; HUMANS; LEUKOCYTE COUNT; LEUKOCYTE REDUCTION PROCEDURES; LIPID METABOLISM; METABOLOMICS; OXYLIPINS; TIME FACTORS;

EID: 84991577800     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.13748     Document Type: Article

References (37)

1. Dhabangi A, Ainomugisha B, Cserti-Gazdewich C, et al. Effect of transfusion of red blood cells with longer vs shorter storage duration on elevated blood lactate levels in children with severe anemia: the TOTAL randomized clinical trial. JAMA 2015;314:2514–23.
2. Lacroix J, Hébert P, Fergusson D, et al. The Age of Blood Evaluation (ABLE) randomized controlled trial: study design. Transfus Med Rev 2011;25:197–205.
3. Fergusson DA, Hébert P, Hogan DL, et al. Effect of fresh red blood cell transfusions on clinical outcomes in premature, very low-birth-weight infants: the ARIPI randomized trial. JAMA 2012;308:1443–51.
4. Zallen G, Offner PJ, Moore EE, et al. Age of transfused blood is an independent risk factor for postinjury multiple organ failure. Am J Surg 1999;178:570–2.
5. Weinberg JA, McGwin G Jr, Griffin RL, et al. Age of transfused blood: an independent predictor of mortality despite universal leukoreduction. J Trauma 2008;65:279–82; discussion 282-4.
6. Zimrin AB, Hess JR. Current issues relating to the transfusion of stored red blood cells. Vox Sang 2009;96:93–103.
7. D'Alessandro A, Kriebardis AG, Rinalducci S, et al. An update on red blood cell storage lesions, as gleaned through biochemistry and omics technologies. Transfusion 2015;55:205–19.
8. Silliman CC, Clay KL, Thurman GW, et al. Partial characterization of lipids that develop during the routine storage of blood and prime the neutrophil NADPH oxidase. J Lab Clin Med 1994;124:684–94.
9. Silliman CC, Moore EE, Kelher MR, et al. Identification of lipids that accumulate during the routine storage of prestorage leukoreduced red blood cells and cause acute lung injury. Transfusion 2011;51:2549–54.
10. Vamvakas EC, Blajchman MA. Transfusion-related immunomodulation (TRIM): an update. Blood Rev 2007;21:327–48.
11. Silliman CC, Kelher MR, Khan SY, et al. Experimental prestorage filtration removes antibodies and decreases lipids in RBC supernatants mitigating TRALI in vivo. Blood 2014;123:3488–95.
12. Wang Y, Armando AM, Quehenberger O, et al. Comprehensive ultra-performance liquid chromatographic separation and mass spectrometric analysis of eicosanoid metabolites in human samples. J Chromatogr A 2014;1359:60–9.
13. D'Alessandro A, D'Amici GM, Vaglio S, et al. Time-course investigation of SAGM-stored leukocyte-filtered red blood cell concentrates: from metabolism to proteomics. Haematologica 2012;97:107–15.
14. D'Alessandro A, Hansen KC, Silliman CC, et al. Metabolomics of AS-5 RBC supernatants following routine storage. Vox Sang 2015;108:131–40.
15. Roback JD, Josephson CD, Waller EK, et al. Metabolomics of ADSOL (AS-1) red blood cell storage. Transfus Med Rev 2014;28:41–55.
16. Zimring JC, Smith N, Stowell SR, et al. Strain-specific red blood cell storage, metabolism, and eicosanoid generation in a mouse model. Transfusion 2014;54:137–48.
17. Nemkov T, Hansen KC, Dumont LJ, et al. Metabolomics in transfusion medicine. Transfusion 2016;56:980–93.
18. Calder PC. Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology? Br J Clin Pharmacol 2013;75:645–62.
19. Brash AR. Arachidonic acid as a bioactive molecule. J Clin Invest 2001;107:1339–45.
20. Bhagat K, Collier J, Vallance P. Vasodilatation to arachidonic acid in humans: an insight into endogenous prostanoids and effects of aspirin. Circulation 1995;92:2113–8.
21. Kuehl FA, Egan RW. Prostaglandins, arachidonic acid, and inflammation. Science 1980;210:978–84.
22. Pérez-Chacón G, Astudillo AM, Balgoma D, et al. Control of free arachidonic acid levels by phospholipases A2 and lysophospholipid acyltransferases. Biochim Biophys Acta 2009;1791:1103–13.
23. Lagarde M, Bernoud-Hubac N, Calzada C, et al. Lipidomics of essential fatty acids and oxygenated metabolites. Mol Nutr Food Res 2013;57:1347–58.
24. Yoshimoto T, Takahashi Y. Arachidonate 12-lipoxygenases. Prostaglandins Other Lipid Mediat 2002;68-69:245–62.
25. Porro B, Songia P, Squellerio I, et al. Analysis, physiological and clinical significance of 12-HETE: a neglected platelet-derived 12-lipoxygenase product. J Chromatogr B Analyt Technol Biomed Life Sci 2014;964:26–40.
26. Dowd PM, Black AK, Woollard PM, et al. Cutaneous responses to 12-hydroxy-5,8,10,14-eicosatetraenoic acid (12-HETE). J Invest Dermatol 1985;84:537–41.
27. Niki E. Biomarkers of lipid peroxidation in clinical material. Biochim Biophys Acta 2014;1840:809–17.
28. Niki E. Lipid peroxidation: physiological levels and dual biological effects. Free Radic Biol Med 2009;47:469–84.
29. Yuan ZX, Rapoport SI, Soldin SJ, et al. Identification and profiling of targeted oxidized linoleic acid metabolites in rat plasma by quadrupole time-of-flight mass spectrometry. Biomed Chromatogr 2013;27:422–32.
30. Zivkovic AM, Yang J, Georgi K, et al. Serum oxylipin profiles in IgA nephropathy patients reflect kidney functional alterations. Metabolomics 2012;8:1102–13.
31. Konkel A, Schunck WH. Role of cytochrome P450 enzymes in the bioactivation of polyunsaturated fatty acids. Biochim Biophys Acta 2011;1814:210–22.
32. Chen P, Véricel E, Lagarde M, et al. Poxytrins, a class of oxygenated products from polyunsaturated fatty acids, potently inhibit blood platelet aggregation. FASEB J 2011;25:382–8.
33. 14C] docosahexaenoic acid by human platelets. J Biol Chem 1983;258:9339–43.
34. Dumont LJ, AuBuchon JP. Evaluation of proposed FDA criteria for the evaluation of radiolabeled red cell recovery trials. Transfusion 2008;48:1053–60.
35. Hess JR; Biomedical Excellence for Safer Transfusion Collaborative. Scientific problems in the regulation of red blood cell products. Transfusion 2012;52:1827–35.
36. Peters AL, van Hezel ME, Cortjens B, et al. Transfusion of 35-day stored RBCs in the presence of endotoxemia does not result in lung injury in humans. Crit Care Med 2016;44:e412–9.
37. Vlaar AP, Kulik W, Nieuwland R, et al. Accumulation of bioactive lipids during storage of blood products is not cell but plasma derived and temperature dependent. Transfusion 2011;51:2358–66.